Search Results for ''

Policy Brief 64, July 2019

The USMCA must be amended to ensure access to affordable drugs in Mexico By Maria Fabiana Jorge The intellectual property rights (IPRs) chapter of the U.S.-Mexico-Canada-Agreement (USMCA) grants longer and broader monopolies to originator pharmaceutical companies than those (more...)

SouthViews No. 181, 25 June 2019

UN tax committee gets a boost through new working methods By Abdul Muheet Chowdhary The UN in May published a document titled ‘Practices and Working Methods for the Committee Of Experts On International Cooperation In Tax Matters’. For those who believe that the (more...)

Policy Brief 63, June 2019

‘Phase 1B’ of the African Continental Free Trade Area (AfCFTA) negotiations By Peter Lunenborg The African Continental Free Trade Area (AfCFTA), which entered into force on 30 May 2019, represents a unique collaborative effort by African countries to bolster regional and (more...)

Declaration of the Non-Aligned Movement Labour Ministers

Declaration of the Non-Aligned Movement Labour Ministers The Ministers of Labour of the Non-Aligned Movement (NAM) reflected on the progress made regarding fundamental labour principles and rights, on the occasion of the centenary of the International Labour Organization (ILO) (more...)

Investment Policy Brief 18, June 2019

Legitimacy Concerns of the Proposed Multilateral Investment Court: Is Democracy Possible? By José Manuel Alvarez Zárate Growing concerns in Europe about international investment regimes and investor-state dispute settlement systems pushed the European Union into (more...)

Policy Brief 62, June 2019

Intellectual Property and Electronic Commerce: Proposals in the WTO and Policy Implications for Developing Countries By Vitor Ido This policy brief explains the mandate of the World Trade Organization (WTO) on electronic commerce under the work program on e-commerce, which was (more...)

Statement, May 2019

South Centre Statement on Access to Biosimilars/Biogeneric Medicines at the WHA 72 The revision of the guidelines on similar therapeutic products mandated by Resolution WHA67.21 is crucial for promoting the availability of and access to biosimilars. The reduction in prices (more...)
0

Your Cart